Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Principal Investigator/Program Director (Last, first, middle): DiCorleto, Paul E. BIOGRAPHICAL SKETCH Provide the following information for the key personnel and other significant contributors in the order listed on Form Page 2. Follow this format for each person. DO NOT EXCEED FOUR PAGES. NAME POSITION TITLE Paul E. DiCorleto, Ph.D. Chairman, Lerner Research Institute eRA COMMONS USER NAME PAULDICORLETO EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.) INSTITUTION AND LOCATION Rensselaer Polytechnic Inst., Troy, NY Cornell University, Ithaca, N University of Washington, Seattle, WA DEGREE (if applicable) YEAR(s) B.S. Ph.D. Postdoc 1973 1978 1978-81 FIELD OF STUDY Chemistry Biochemistry Vascular Cell Biology A. Positions and Honors: Professional Positions 1981-1982 Project Scientist, Dept. of Cardiovascular Research, Cleveland Clinic Foundation 1982-1985 Associate Staff, Department of Cardiovascular Research, Cleveland Clinic Foundation 1985-1989 Staff, Department of Brain and Vascular Research, Cleveland Clinic Foundation 1985-present Adjunct Faculty, Department of Biology, Cleveland State University 1989-present Adjunct Faculty, Department of Biology, Case Western Reserve University 1992-present Professor, Department of Molecular and Cellular Biochemistry, Ohio State University 1989-present Professor, Department of Physiology and Biophysics, Case Western Reserve University 1996-1999 Vice Chair, Cleveland Clinic Lerner Research Institute 1997-2001 Associate Chief of Staff, Cleveland Clinic Foundation 1989-2002 Chairman, Department of Cell Biology, Cleveland Clinic Lerner Research Institute 2003-present Chairman, Department of Molecular Medicine, Case School of Medicine 2002-present Chairman, Lerner Research Institute, Cleveland Clinic Foundation Awards and Other Professional Activities: 1985-1990: NIH Research Career Development Award; 1988: Co-Chair with Dr. S. Schwartz of First Gordon Conference on Vascular Cell Biology; 1987-1991: Member and Chair, NIH Cellular Biology and Physiology II Study Section; 1991: Visiting Scholar of the British Heart Fund; 1995-1999: Member, Heart, Lung and Blood Program Project Review Committee, NHLBI; 1999- present: Member, Advisory Panel on Research, Association of American Medical Colleges; 2001: American Heart Association Special Recognition Award of the ATVB Council; 2002-2003: President, North American Vascular Biology Organization B. Selected Relevant Publications (from over 90): DiCorleto, P.E. and Bowen-Pope, D.F. (1983). Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc. Natl. Acad. Sci. 80: 1919-1923. Morel, D.W., DiCorleto, P.E. and Chisolm, G.M. (1984) Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4: 357-364. DiCorleto, P.E. and de la Motte, C.A. (1985) Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells. J. Clin. Invest. 75: 1153-1161. Fox, P.L. and DiCorleto, P.E. (1986) Modified low density lipoproteins suppress production of platelet-derived growth factor by cultured endothelial cells. Proc. Natl. Acad. Sci. USA 83: 4774-4778. Fox, P.L., Chisolm, G.M., and DiCorleto, P.E. (1987) Lipoprotein-mediated inhibition of endothelial cell production of PDGF-like protein depends on free radical lipid peroxidation. J. Biol. Chem. 262: 6046-6054. Fox, P.L. and DiCorleto, P.E. (1988) Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 241: 453-456. PHS 398/2590 (Rev. 09/04) Page ____ Biographical Sketch Format Page Principal Investigator/Program Director (Last, first, middle): DiCorleto, Paul E. DiCorleto, P.E. and de la Motte, C.A. (1989) Thrombin causes increased monocytic cell adhesion to endothelial cells through a protein kinase C-dependent pathway. Biochem. J. 264: 71-77. DiCorleto, P.E. and de la Motte, C.A. (1989) Role of cell surface carbohydrate moieties in monocytic cell adhesion to endothelium in vitro. J. Immunol. 143: 3666-3672. Shankar, R., de la Motte, C.A., and DiCorleto, P.E. (1992) Thrombin stimulates platelet-derived growth factor production and monocyte adhesion through distinct intracellular pathways in human aortic EC. Am. J. Physiol. 262: C199-C206. Shankar, R., de la Motte, C.A., and DiCorleto, P.E. (1992) 3-Deazaadenosine inhibits thrombin-stimulated PDGF production and ELAM-1 mediated monocytic cell adhesion in human aortic EC. J. Biol. Chem. 267: 9376-9382. Shankar, R., de la Motte, C.A., Poptic, E.J. and DiCorleto, P.E. (1994) Thrombin receptor-activating peptides differentially stimulate PDGF production, monocytic cell adhesion and E-selectin expression in human umbilical vein endothelial cells. J. Biol. Chem., 269: 13936-13941. Chisolm, G.M., Ma, G., Irwin, K.C., Martin, L.L., Gunderson, K.G., Linberg, L.F., Morel, D.W., and DiCorleto, P.E. (1994) 7b-hydroperoxycholest-5-en-3b-ol, a component of human atherosclerotic lesions, is a primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA , 91: 11452-11456. Faruqi, R., de la Motte, C.A., and DiCorleto, P.E. (1994) a-Tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest., 94: 592-600. Soyombo, A.A. and DiCorleto, P.E. (1994) Stable expression of human PDGF B chain by bovine aortic endothelial cells: matrix association and selective proteolytic cleavage by thrombin. J. Biol. Chem., 269: 17734-17740. Scarpati, E.M. and DiCorleto, P.E. (1996) Identification of a thrombin-response element in the human platelet-derived growth factor B chain (c-sis) promoter. J. Biol. Chem., 271:3025-3032. Faruqi, R.M., Poptic, E.J., Faruqi, T.R., de la Motte, C., and DiCorleto, P.E. (1997) Distinct mechanisms for Nacetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression. Am. J. Physiol., 273: H817-H826. Faruqi, T.R. and DiCorleto, P.E. (1997) IFN-stranded RNA-induced E-selectin expression in human endothelial cells. J. Immunol., 159: 3989-3994. Faruqi, T.R., Erzurum, S.C., Kaneko, F.T., and DiCorleto, P.E. (1997) Role of nitric oxide in poly(I-C)-induced endothelial cell expression of leukocyte adhesion molecules. Am. J. Physiol., 273: H2490-2497. Van Heek, M., Schmitt, D., Toren, P., Cathcart, M.K., and DiCorleto, P.E., (1998) Cholesteryl HPODE from oxidized LDL inactivates platelet-derived growth factor. J. Biol. Chem., 273: 19405-19410. Patel, C., Sharangpani, R. Bandyopadhyay, S., and DiCorleto, P.E. (1999) Endothelial cells express a novel, TNF- -regulated variant of HOXA9. J. Biol. Chem., 274:1415-1422. Stenina, O. I., Poptic, E.J. and DiCorleto, P.E. (2000) Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells. J. Clin. Invest., 106, 579 - 587. Guetta, E., Scarpati, E. and DiCorleto, P.E. (2001) The effect of cytomegalovirus immediate early gene products on endothelial cell gene activity. Cardiovasc. Res., 50:538-46. Mao, C.D., Hoang, P., and DiCorleto, P.E. (2001) Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells. J. Biol. Chem., 276:26180-26188. Stenina, O. I., Shaneyfelt, K., and DiCorleto, P.E. (2001) Thrombin induces the release of the Y-box protein dpbB from mRNA: a new mode of transcription factor activation, Proc. Natl. Acad. Sci. USA, 98:7277-7282. Byzova, T.V., Goldman, C.K., Jankau, J., Chen, J., Cabrera, G., Achen, M.G., Stacker, S.A., Carnevale, K.A., Siemionow M., Steven R. Deitcher S.R., and DiCorleto, P.E. (2002) Adenovirus encoding VEGF-D induces tissue-specific vascular patterns in vivo. Blood, 99:4434-42. Askari, A.T., Unzek, S., Popovic, Z.B., Goldman, C.K., Forudi, F., Kiedrowski, M., Rovner, A., Ellis, S.G., Thomas, J.T., DiCorleto, P.E., Topol, E.J., Penn, M.S. (2003) Effect of Stromal- cell-derived factor-1 on stem cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362(9385):697-703. Mazumder, B., Sampath, P., Seshadri, V., Maitra, R.K., DiCorleto, P.E. and Fox, P.L. (2003) Regulated release of L13a from the 60S ribosomal subunit: A mechanism of transcript-specific translational control. Cell, 115:187-198. Askari A, Unzek S, Goldman CK, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS. (2004) Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy J Am Coll Cardiol. 43:1908-14. Tian, X., Kadaba,, R., You, S.-A., Liu, M., Timur, A.A., Yang, L., Chen, Q., Szafranski, P., Rao, S., Wu, L., Housman, D.E., DiCorleto, P.E., Driscoll, D.J., Borrow, J., and Wang, Q. (2004) Identification of an angiogenic factor that when mutated cause susceptibility to Klippel-Trenaunay syndrome, Nature, 427:640-5. Chandrasekharan, U.N., Yang, L., Walters, A., Howe, P.H. and DiCorleto, P.E. (2004) Role of CL-100, a dual specificity phosphatase, in thrombin-induced endothelial cell activation. J. Biol. Chem., 279:46678-85. PHS 398/2590 (Rev. 09/04) Page ____ Biographical Sketch Format Page Principal Investigator/Program Director (Last, first, middle): DiCorleto, Paul E. C. Research Support Research Projects Ongoing or Completed During the Last Three Years: “Regulation of Endothelial Cell Activation by Thrombin and Cytokines”: Project 4 of Program Project “Vascular Cell Function and Atherosclerosis” Principal Investigator: Paul E. DiCorleto, Ph.D., (P.I. of Program Project, of Project 4 & Cell Culture Core) Agency: National Heart, Lung and Blood Institute Type: P01 (HL29582, years 21 - 25) Period: 7/1/03 - 6/30/08 This project explores signaling pathways and transcription factors that play a role in EC expression of activation genes in response to thrombin and TNF. PHS 398/2590 (Rev. 09/04) Page ____ Biographical Sketch Format Page